Bir COVID-19 Hastasında Profilaktik Subkutan Enoksaparin Tedavisi Sonrası Rektus Kılıf Hematomu
Abstract
Keywords
References
- 1- Johns Hopkins Coronavirus Resource Center [Internet]. John-Hopkins University &Medicine;2020 [cited ].2020Available form:https://coranavirüs.jhu.edu/data/mortality.
- 2- Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584 (7821):430-6.
- 3-Connors JM, Levy JH. Thromboinflammation and the hypercoagulability of COVID-19. J Thromb Haemost. 2020 ;18(7):1559-61.
- 4- Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z,et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China:a retrospective cohort study. Lancet. 2020;395(10229):1054-62.
- 5-Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):2033-40.
- 6-Cherry WB, Mueller PS. Rectus sheath hematoma:review of 126 cases at a single institution. Medicine (Baltimore). 2006;85(2):105-10.
- 7- Velicki L, Cemerlić-Adić N, Bogdanović D, Mrdanin T. Rectus sheath haematoma: enoxaparin-related complication. Acta Clin Belg. 2013 ;68(2):147-9.
- 8-Denard PJ, Fetter JC, Zacharski LR. Rectus sheath hematoma complicating low-molecular weight heparin therapy. Int J Lab Hematol. 2007;29:190-4.
Details
Primary Language
Turkish
Subjects
Clinical Sciences
Journal Section
Case Report
Authors
Muharrem Bayrak
This is me
Türkiye
Kenan Çadırcı
This is me
Türkiye
Mustafa Kahraman
This is me
Türkiye
Publication Date
August 1, 2021
Submission Date
December 6, 2020
Acceptance Date
June 7, 2021
Published in Issue
Year 2021 Volume: 11 Number: 2